GO:0005960 glycine cleavage complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005960 (glycine cleavage complex) is a mitochondrial multienzyme complex that reversibly oxidizes glycine, linking glycine catabolism to one-carbon (C1) metabolism.
• The complex comprises four proteins: P-protein (glycine dehydrogenase, decarboxylating), H-protein (lipoyl-GcvH), T-protein (aminomethyltransferase), and L-protein (dihydrolipoamide dehydrogenase).
• The glycine cleavage system is a major source of one-carbon units for folate-mediated biosynthesis and is essential for cellular methylation and nucleotide synthesis.
• Dysregulation of the glycine cleavage complex is implicated in cancer metabolic reprogramming, hyperglycinemia, and parasite-specific folate metabolism [1,2,6].
• The H-protein serves as a mobile lipoyl carrier and its lipoylation is critical for complex activity; its N-terminal degradation is controlled by a glycine-specific N-degron pathway.
• Research tools include CRISPR knockout/knock-in models, structural biology (NMR, crystallography), and metabolic flux analysis to dissect complex function [4,8].
Description
The glycine cleavage complex (GO:0005960) is a mitochondrial multienzyme system that catalyzes the reversible oxidation of glycine, producing carbon dioxide, ammonia, and a one-carbon unit transferred to tetrahydrofolate. This complex is highly conserved from bacteria to humans and plays a central role in glycine homeostasis and one-carbon metabolism. In eukaryotes, it is located in the mitochondrial matrix and is composed of four distinct proteins: P-protein (glycine dehydrogenase, decarboxylating), H-protein (lipoyl-GcvH), T-protein (aminomethyltransferase), and L-protein (dihydrolipoamide dehydrogenase). The glycine cleavage system is not only a catabolic pathway for glycine but also a major source of one-carbon units for nucleotide synthesis, methylation reactions, and serine-glycine interconversion. Its dysfunction leads to non-ketotic hyperglycinemia, a severe neurological disorder, and its altered activity is observed in cancer cells where glycine metabolism supports rapid proliferation [1,6]. In Plasmodium falciparum, a glycine-cleavage complex is part of the folate one-carbon metabolism, highlighting its potential as an antimalarial target. Understanding the structure, assembly, and regulation of the glycine cleavage complex is therefore critical for both basic biochemistry and therapeutic development.
glycine cleavage complex At A Glance
| GO ID | GO:0005960 |
|---|---|
| GO term | glycine cleavage complex |
| Ontology | cellular_component |
| Synonym | glycine cleavage system; glycine decarboxylase complex; glycine dehydrogenase complex (decarboxylating); glycine dehydrogenase (decarboxylating) complex; glycine synthase complex |
| Major function | Reversible oxidation of glycine to CO2, NH3, and a one-carbon unit (5,10-methylene-THF) |
| Subunit composition | P-protein (GcvP), H-protein (GcvH), T-protein (GcvT), L-protein (GcvL) |
| Cofactors | Pyridoxal phosphate (P-protein), lipoic acid (H-protein), tetrahydrofolate (T-protein), FAD (L-protein) |
| Cellular location | Mitochondrial matrix in eukaryotes; cytoplasm in bacteria |
| Related pathways | Glycine, serine, and threonine metabolism; one-carbon metabolism; folate biosynthesis [1,2] |
What Is GO:0005960?
The glycine cleavage complex (GO:0005960) is a protein complex that catalyzes the reversible oxidation of glycine. In Escherichia coli, it consists of four components: dihydrolipoamide dehydrogenase (L-protein), glycine dehydrogenase (decarboxylating) (P-protein), lipoyl-GcvH-protein (H-protein), and aminomethyltransferase (T-protein). This definition captures the core enzymatic machinery responsible for glycine cleavage and one-carbon transfer.
Why Is glycine cleavage complex Important in Cell Biology?
The glycine cleavage complex is a metabolic hub that connects glycine catabolism to one-carbon metabolism, influencing nucleotide synthesis, methylation, and redox balance [1,6]. Its activity is essential for maintaining glycine homeostasis; defects cause non-ketotic hyperglycinemia, a devastating neurological disorder. In cancer, the complex is often upregulated to support rapid proliferation by supplying one-carbon units and maintaining redox balance. In Plasmodium falciparum, the glycine cleavage complex is part of the folate pathway and is a potential drug target. Moreover, the H-protein is subject to quality control via a glycine-specific N-degron pathway, linking the complex to protein stability and N-myristoylation. Thus, studying this complex has broad implications for inherited metabolic diseases, oncology, and infectious diseases.
• Provides one-carbon units for purine and thymidylate synthesis, essential for DNA replication and repair.
• Maintains glycine homeostasis; its deficiency leads to hyperglycinemia and neurological impairment.
• Supports cancer cell proliferation by fueling one-carbon metabolism and redox balance.
• Serves as a metabolic link between glycine, serine, and folate cycles [1,6].
• Is a potential target for antimalarial drugs due to its role in parasite folate metabolism.
• Regulates protein stability via the glycine-specific N-degron pathway involving H-protein.
• Its structural components are studied by NMR and crystallography for drug design.
• Can be engineered for C1-based biosynthesis in biotechnology applications.
• Dysregulation is associated with non-ketotic hyperglycinemia and certain cancers [1,6].
• Plays a role in HIV-1 infection through prion-like low complexity regions in host proteins.
What Happens During glycine cleavage complex?
Glycine Decarboxylation by P-Protein
In simple terms: The P-protein removes carbon dioxide from glycine and transfers the remaining methylamine group to the H-protein.
The first step of glycine cleavage is catalyzed by the P-protein (glycine dehydrogenase, decarboxylating), a pyridoxal phosphate-dependent enzyme. It binds glycine and catalyzes its decarboxylation, forming a methylamine intermediate that is transferred to the lipoamide cofactor of the H-protein. This step is reversible and is the entry point for glycine into the complex.
Methylamine Transfer to H-Protein
In simple terms: The H-protein acts as a shuttle, carrying the methylamine group to the T-protein.
The H-protein (lipoyl-GcvH) is a small, lipoylated protein that accepts the methylamine group from the P-protein, forming an intermediate that is then delivered to the T-protein. The lipoamide arm of H-protein undergoes redox-dependent conformational changes to facilitate substrate channeling. The H-protein is essential for complex assembly and activity, and its lipoylation is a prerequisite for function.
One-Carbon Transfer by T-Protein
In simple terms: The T-protein releases ammonia and transfers the one-carbon unit to tetrahydrofolate.
The T-protein (aminomethyltransferase) catalyzes the transfer of the methylamine group from the H-protein to tetrahydrofolate (THF), producing 5,10-methylene-THF and ammonia. This reaction is the key step that links glycine cleavage to one-carbon metabolism. The T-protein uses a folate-binding site and is regulated by the availability of THF.
L-Protein Regenerates the Lipoyl Cofactor
In simple terms: The L-protein recycles the H-protein so it can accept another glycine molecule.
The L-protein (dihydrolipoamide dehydrogenase) is a flavin-dependent enzyme that reoxidizes the reduced lipoamide of the H-protein, using NAD+ as an electron acceptor. This regeneration step is essential for continuous catalytic turnover. The L-protein is shared with other multienzyme complexes such as pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase.
Overall Reversibility and Metabolic Context
In simple terms: The complex can run in reverse to synthesize glycine from one-carbon units, depending on cellular needs.
The glycine cleavage complex is reversible; under certain conditions, it can synthesize glycine from 5,10-methylene-THF, CO2, and ammonia. This reversibility allows the complex to contribute to glycine biosynthesis when demand is high. The direction of flux is regulated by substrate availability and the cellular redox state.
Key Genes Involved in GO:0005960 glycine cleavage complex
The following genes encode the core subunits and auxiliary factors of the glycine cleavage complex across species.
| Gene | Major Role | Research Relevance |
|---|---|---|
| gcvP (P-protein) | Glycine dehydrogenase (decarboxylating); catalyzes glycine decarboxylation | Target for metabolic engineering and inhibitor design [6,8] |
| gcvH (H-protein) | Lipoyl carrier protein; shuttles methylamine group | Subject to N-degron quality control; structural studies [3,4] |
| gcvT (T-protein) | Aminomethyltransferase; transfers one-carbon unit to THF | Key for one-carbon flux; mutations linked to hyperglycinemia |
| gcvL (L-protein) | Dihydrolipoamide dehydrogenase; regenerates lipoamide | Shared with other dehydrogenase complexes; redox regulation |
| GLDC (human P-protein) | Glycine decarboxylase; mutations cause non-ketotic hyperglycinemia | Disease modeling; cancer metabolism [1,6] |
| AMT (human T-protein) | Aminomethyltransferase; mutations cause hyperglycinemia | Diagnostic marker; enzyme assays |
| GCSH (human H-protein) | Glycine cleavage system H protein; lipoylation required | Post-translational regulation; N-degron pathway |
| DLD (human L-protein) | Dihydrolipoamide dehydrogenase; E3 component | Defects cause E3 deficiency; redox biology |
| PfGcvP (Plasmodium) | Putative glycine cleavage complex P-protein | Antimalarial target; folate metabolism |
| PfGcvH (Plasmodium) | Putative H-protein | Parasite-specific metabolism |
| PfGcvT (Plasmodium) | Putative T-protein | Drug target validation |
| PfGcvL (Plasmodium) | Putative L-protein | Redox metabolism in parasite |
| LPD1 (yeast) | Dihydrolipoamide dehydrogenase | Model for mitochondrial metabolism |
| GCV1 (yeast) | Glycine decarboxylase P-protein | Genetic studies of glycine metabolism |
| GCV2 (yeast) | Aminomethyltransferase T-protein | One-carbon metabolism |
| GCV3 (yeast) | H-protein | Lipoylation and assembly |
| gcvH (E. coli) | Lipoyl-GcvH protein | NMR structure and backbone assignments |
| gcvT (E. coli) | Aminomethyltransferase | Enzyme kinetics and mechanism |
How Is glycine cleavage complex Regulated?
The glycine cleavage complex is regulated at multiple levels. Transcriptionally, the genes encoding its subunits are induced by glycine availability and one-carbon demand. Post-translationally, the H-protein is regulated by lipoylation and by a glycine-specific N-degron pathway that targets it for degradation when N-myristoylation is impaired. The complex is also sensitive to redox state, as the L-protein requires NAD+ and FAD for activity. In cancer cells, oncogenic signaling such as mTOR can indirectly upregulate one-carbon metabolism, including glycine cleavage, to support proliferation. In Plasmodium, the complex is part of the folate pathway and is regulated by the parasite's metabolic needs.
glycine cleavage complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GLDC | Non-ketotic hyperglycinemia; cancer metabolism | CRISPR knockout in HEK293 or patient iPSCs; metabolic flux analysis [1,6] |
| AMT | Non-ketotic hyperglycinemia | Knockout zebrafish or mouse models; enzyme activity assays |
| GCSH | Hyperglycinemia; N-degron regulation | Point mutation knock-in in cell lines; proteasome inhibition studies [3,6] |
| DLD | E3 deficiency; redox disorders | Knockout in hepatocytes; mitochondrial function assays |
| PfGcvP | Malaria parasite folate metabolism | CRISPR knockout in P. falciparum; antimalarial drug screening |
Non-Ketotic Hyperglycinemia (NKH)
Mutations in GLDC, AMT, or GCSH cause non-ketotic hyperglycinemia, a rare autosomal recessive disorder characterized by elevated glycine in blood and cerebrospinal fluid, leading to severe neurological symptoms such as seizures, hypotonia, and developmental delay. The glycine cleavage complex is defective in NKH, and diagnosis often involves enzyme assays or genetic testing.
Cancer Metabolism
The glycine cleavage complex is upregulated in many cancers to provide one-carbon units for nucleotide synthesis and to maintain redox balance. Serine and glycine metabolism, including the glycine cleavage system, supports rapid cancer cell proliferation and is a target for metabolic therapy. Inhibition of the complex can reduce tumor growth in preclinical models.
Infectious Diseases
Plasmodium falciparum possesses a glycine-cleavage complex as part of its folate one-carbon metabolism, which is essential for parasite survival. This complex differs from the human counterpart and is a potential target for antimalarial drugs. Similarly, HIV-1 infection involves prion-like low complexity regions that may interact with host metabolic proteins, including those in glycine metabolism.
From glycine cleavage complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GLDC affect glycine flux? | CRISPR knockout of GLDC in cancer cell lines (e.g., HeLa, HCT116) |
| How do point mutations in AMT cause NKH? | Knock-in of patient mutations in HEK293 cells; enzyme assays |
| What is the role of H-protein lipoylation? | Tagged knock-in of GCSH with lipoylation site mutations [3,4] |
| Can overexpression of GCV subunits enhance C1 biosynthesis? | Overexpression of gcvP, gcvH, gcvT, gcvL in E. coli or yeast |
| How does the complex assemble in mitochondria? | Knock-in of fluorescent tags (e.g., GFP) into endogenous loci; live-cell imaging |
| Is the Plasmodium complex essential for parasite survival? | CRISPR knockout of PfGcv genes in P. falciparum; growth assays |
How to Study the glycine cleavage complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 13C metabolic flux analysis | Flux through glycine cleavage and one-carbon pathways | Cancer metabolism studies |
| NMR spectroscopy | Protein structure and dynamics of H-protein | Structural biology of complex components |
| Enzyme activity assay | CO2 release or THF conversion | Diagnosis of NKH; inhibitor screening |
| CRISPR knockout screens | Gene essentiality and metabolic dependencies | Identifying synthetic lethal interactions |
| Western blot | Protein expression and lipoylation status | Validating knockout or knock-in models |
| Immunofluorescence | Subcellular localization of complex subunits | Mitochondrial assembly studies |
| qRT-PCR | mRNA levels of GCV genes | Transcriptional regulation studies |
| Proteomics | Protein interactions and post-translational modifications | Identifying novel regulators |
Metabolic Flux Analysis
Isotope tracing with 13C-labeled glycine or serine can quantify flux through the glycine cleavage complex in cells and tissues. This method measures the production of 13C-labeled one-carbon units and CO2, providing direct readout of complex activity.
Structural Biology (NMR and Crystallography)
NMR spectroscopy and X-ray crystallography have been used to determine the structures of individual components, such as the E. coli H-protein, and to study complex assembly. Backbone chemical shift assignments of GcvH provide insights into its interactions.
Enzyme Activity Assays
In vitro assays using purified components or cell lysates measure the release of CO2 or the formation of 5,10-methylene-THF. These assays are used to diagnose NKH and to screen for inhibitors.
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout screens can identify genes that modulate glycine cleavage complex activity or sensitivity to metabolic inhibitors. Such screens have revealed links to one-carbon metabolism and cancer cell fitness.
How CRISPR Can Be Used to Study GO:0005960 glycine cleavage complex
Knockout
CRISPR knockout of genes encoding glycine cleavage complex subunits (e.g., GLDC, AMT, GCSH, DLD) can abolish complex activity, leading to glycine accumulation and altered one-carbon metabolism. These models are used to study NKH and cancer metabolic dependencies [1,6].
Point Mutation
Point mutations identified in NKH patients (e.g., in GLDC or AMT) can be introduced via CRISPR base editing or homology-directed repair to create isogenic cell lines. These models help dissect the molecular basis of enzyme dysfunction and test pharmacological chaperones.
Knock-in
Knock-in of epitope tags (e.g., FLAG, GFP) into endogenous GCV genes allows for live-cell imaging, immunoprecipitation, and proteomic analysis of complex assembly and dynamics. Tagged H-protein can be used to study lipoylation and N-degron regulation [3,4].
Overexpression
Overexpression of the entire glycine cleavage complex or individual subunits in bacterial or mammalian cells can enhance one-carbon production for biotechnology applications or study the effects of complex amplification on metabolism.
How EDITGENE Supports glycine cleavage complex Research
Researchers studying glycine cleavage complex-related genes often need to determine whether a candidate gene is causally involved in metabolic regulation, disease pathogenesis, or drug response. EDITGENE provides comprehensive CRISPR-based services to create precise cellular models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for glycine cleavage complex research.
Frequently Asked Questions About glycine cleavage complex
What is the glycine cleavage complex?
The glycine cleavage complex (GO:0005960) is a mitochondrial multienzyme system that reversibly oxidizes glycine to CO2, NH3, and a one-carbon unit, playing a key role in one-carbon metabolism.
What genes are involved in the glycine cleavage complex?
The core genes are GLDC (P-protein), AMT (T-protein), GCSH (H-protein), and DLD (L-protein) in humans, with homologs in bacteria and parasites.
What is the function of GO:0005960?
GO:0005960 catalyzes the reversible oxidation of glycine, linking glycine catabolism to folate-mediated one-carbon metabolism.
How is the glycine cleavage complex regulated?
It is regulated transcriptionally by glycine availability, post-translationally by lipoylation and the N-degron pathway, and by redox state [3,6].
What diseases are associated with glycine cleavage complex mutations?
Mutations cause non-ketotic hyperglycinemia, and altered activity is linked to cancer and infectious diseases [1,2,6].
What are the subunits of the glycine cleavage complex?
The complex consists of P-protein (glycine dehydrogenase), H-protein (lipoyl carrier), T-protein (aminomethyltransferase), and L-protein (dihydrolipoamide dehydrogenase).
How can I study the glycine cleavage complex using CRISPR?
CRISPR knockout, point mutation knock-in, tagged knock-in, and overexpression models can be generated to study gene function, assembly, and metabolic flux [1,6].
Is the glycine cleavage complex a drug target?
Yes, it is a potential target for cancer therapy and antimalarial drugs due to its role in one-carbon metabolism [1,2].
What is the role of the H-protein in the glycine cleavage complex?
The H-protein shuttles the methylamine group between P-protein and T-protein and is regulated by lipoylation and N-degron-mediated degradation [3,6].
Where is the glycine cleavage complex located in cells?
In eukaryotes, it is located in the mitochondrial matrix; in bacteria, it is in the cytoplasm.
Conclusion
The glycine cleavage complex (GO:0005960) is a central metabolic machine that connects glycine catabolism to one-carbon metabolism, with profound implications for inherited metabolic diseases, cancer, and infectious diseases. Its four-subunit architecture and reversible mechanism make it a fascinating subject for structural and functional studies. Advances in CRISPR-based models and metabolic flux analysis continue to unravel its regulation and therapeutic potential.
References
- 1. Amelio I et al.. 2014. Serine and glycine metabolism in cancer.. Trends Biochem Sci 39(4):191-8 PMID: 24657017
- 2. Salcedo E et al.. 2005. A glycine-cleavage complex as part of the folate one-carbon metabolism of Plasmodium falciparum.. Trends Parasitol 21(9):406-11 PMID: 16039160
- 3. Timms RT et al.. 2019. A glycine-specific N-degron pathway mediates the quality control of protein N-myristoylation.. Science 365(6448) PMID: 31273098
- 4. Yadav U et al.. 2018. Backbone chemical shift assignments of the glycine cleavage complex H protein of Escherichia coli.. Biomol NMR Assign 12(1):163-165 PMID: 29335837
- 5. Wei G et al.. 2022. Prion-like low complexity regions enable avid virus-host interactions during HIV-1 infection.. Nat Commun 13(1):5879 PMID: 36202818
- 6. Kikuchi G et al.. 2008. Glycine cleavage system: reaction mechanism, physiological significance, and hyperglycinemia.. Proc Jpn Acad Ser B Phys Biol Sci 84(7):246-63 PMID: 18941301
- 8. Ren J et al.. 2022. Understanding and Engineering Glycine Cleavage System and Related Metabolic Pathways for C1-Based Biosynthesis.. Adv Biochem Eng Biotechnol 180:273-298 PMID: 35294558
